Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C19orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CAPRIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKSG49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
GLG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PTPRR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF710 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTAN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM131A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on